Archive for the ‘HIV / AIDS’ Category
Tuesday, August 12th, 2008
About 40% of adults in the U.S. have ever been tested for HIV, according to a study published Friday in CDC's Morbidity and Mortality Weekly Report to coincide with the XVII International AIDS Conference in Mexico City, the Los Angeles Times reports (Maugh, Los Angeles Times, 8/8). "In 2007, ...
Posted in HIV / AIDS | No Comments »
Monday, August 11th, 2008
Many sex and HIV/AIDS education programs around the world focus on the risks of unsafe sex, which can leave young people unprepared to deal with their sexuality or lead sexually fulfilling lives, experts said at a satellite session on comprehensive sex education at the XVII International AIDS Conference in Mexico ...
Posted in HIV / AIDS | No Comments »
Monday, August 11th, 2008
Isentress® (raltegravir), Merck & Co., Inc.'s first-in-class integrase inhibitor, in combination with two other anti-HIV medicines, reduced HIV viral load to undetectable levels (less than 50 copies/mL) in 83 percent of previously untreated (treatment-na?ve) HIV-infected patients which was comparable to that seen with efavirenz (Sustiva®/STOCRIN®)*, which reduced HIV viral load ...
Posted in HIV / AIDS | No Comments »
Monday, August 11th, 2008
Antibodies that prevent some HIV-positive people from progressing to AIDS could be used to develop microbicides or a vaccine to prevent HIV-negative people from contracting the virus, according to research presented Thursday at the XVII International AIDS Conference in Mexico City, the Washington Post reports. According to the research, conducted ...
Posted in HIV / AIDS | No Comments »
Monday, August 11th, 2008
A report released on Wednesday at the XVII International AIDS Conference in Mexico City called for more attention to and funding for the role of those participating in home-based care for people with HIV/AIDS in Zimbabwe, Zimbabwe's Herald/AllAfrica.com reports.The report was compiled by the Southern Africa HIV and AIDS Information ...
Posted in HIV / AIDS | No Comments »
Monday, August 11th, 2008
Although antiretroviral drugs have become "so effective" that a 20-year-old HIV-positive person in a wealthy country can now expect to live another 43 years on average -- "close to a normal lifespan" -- the "near-miraculous effects" of the drugs highlight the need to treat as many people as possible worldwide, ...
Posted in HIV / AIDS | No Comments »
Monday, August 11th, 2008
More than 17% of HIV-positive patients in 28 China provinces developed resistance to at least one available HIV/AIDS drug by 2007 and 2007, Chinese government researchers announced at the XVII International AIDS Conference in Mexico City, Reuters reports. Those who developed drug resistance tended to have low or unstable incomes, ...
Posted in HIV / AIDS | No Comments »
Monday, August 11th, 2008
Argos Therapeutics and Université de Montréal announced the presentation of new information on Argos' process for developing dendritic cell-based immunotherapies for HIV. Results from the study demonstrate that loading monocyte-derived dendritic cells with combinations of HIV antigen RNA stimulates the expansion of HIV-specific T cells, which attack and kill HIV-infected ...
Posted in HIV / AIDS | No Comments »
Monday, August 11th, 2008
Discussions about how to manage AIDS in the long term and how to improve prevention efforts globally took center stage at this year's International AIDS Conference (IAC) held in Mexico City. Unlike previous IAC conferences, this year's event did not have a plenary session focused on vaccines. But that ...
Posted in HIV / AIDS | No Comments »
Monday, August 11th, 2008
In a new report released today, an international panel of AIDSexperts calls on global leaders to aggressively expand HIV prevention programs aimed at reducinghigh-risk behaviors, including unsafe sex and drug use. Citing hundreds of clinical trials andobservational studies, the report concludes that behavior-change programs are highly effective forpreventing HIV, ...
Posted in HIV / AIDS | No Comments »
Sunday, August 10th, 2008
Bristol-Myers Squibb Company (NYSE: BMY) and the Bristol-Myers Squibb Foundation announced the launch of the SECURE THE FUTURE® Technical Assistance Program (TAP), an innovative skills transfer initiative designed to enable communities in countries severely affected by HIV/AIDS to optimize the delivery of services for the comprehensive treatment and management of ...
Posted in HIV / AIDS | No Comments »
Saturday, August 9th, 2008
National Institute of Allergy and Infectious Diseases Director Anthony Fauci and UNAIDS Executive Director Peter Piot on Wednesday at the XVII International AIDS Conference in Mexico City discussed progress in HIV/AIDS treatments and prevention efforts and the future of HIV treatment, Bloomberg reports.According to Fauci, HIV-positive people eventually might be ...
Posted in HIV / AIDS | No Comments »
Saturday, August 9th, 2008
Participants at the XVII International AIDS Conference in Mexico City on Wednesday heard about the future of the epidemic from a variety of perspectives. According to Anthony Fauci, M.D., Director of the National Institute of Allergy and Infectious Diseases, research possibilities are "bright and promising." "However, here ...
Posted in HIV / AIDS | No Comments »
Saturday, August 9th, 2008
The Southern Africa HIV and AIDS Information Dissemination Service launched a tool kit on children and antiretroviral therapy on Sunday at the XVII International AIDS Conference, Zimbabwe's Herald/AllAfrica.com reports. According to SAfAIDS, the tool kit is a "vibrant" package of informative and interactive material to be used by children and ...
Posted in HIV / AIDS | No Comments »
Saturday, August 9th, 2008
Mexican migrant workers significantly change their sex habits and increase their risk for HIV after they arrive in the U.S., according to a study conducted by the Pilot Program of California-Mexico Epidemiology Vigilance and released on Tuesday at the XVII International AIDS Conference in Mexico City, AFP/Google.com reports. The ...
Posted in HIV / AIDS | No Comments »
